Sales data specialists Cegedim to buy rivals Dendrite

March 2, 2007
Sales and Marketing Cegedim

French specialist pharmaceutical database and software company Cegedim is to buy its US-based rivals Dendrite for $751 million.Dendrite's board of …

New clinical trials network to boost patient recruitment in UK

March 2, 2007
Research and Development

Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …

Novartis’ 2-in-1 blood pressure drug Exforge launched in the UK

March 2, 2007
Sales and Marketing

Novartis new hypertension drug Exforge has been launched in the UK, promising to help more patients lower their blood pressure …

Court orders withdrawal of generic Lipitor in Denmark

March 2, 2007
Sales and Marketing

Pfizer has gained a court injunction ordering the withdrawal of a generic version of its top-seller Lipitor (atorvastatin).Indian generics company …

Two products fuelling Actelion’s growth spurt

March 2, 2007
Sales and Marketing

Swiss specialist pharma company Actelion saw sales revenue rise 43% in 2006 thanks to rapid growth in its two products, …

US approval for Shire’s Vyvanse

February 28, 2007
Sales and Marketing

Shire and New River Pharmaceuticals have been given the green light by the FDA to market anti-ADHD drug Vyvanse. Shire, …

Helping UK pharma communicate

February 28, 2007
Medical Communications, Sales and Marketing HCA, assocation, public relations

The Healthcare Communications Association (HCA), which aims to promote excellence and best practice within pharmaceutical industry communications, has reached its …

Radical overhaul of NHS prescription drug prices recommended

February 20, 2007
Sales and Marketing pricing

 The Office of Fair Trading wants to reform the way prescription medicines are priced to reflect the benefits they bring …

Learning from Northwick Park

February 19, 2007
Research and Development UK, biotech, clinical trials, drug safety

In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …

Doctors attack ‘nonsensical’ NHS cost-cutting

February 19, 2007

The British Medical Association has branded as "nonsensical" the situation whereby hospitals delay routine operations because of financial problems.The doctors' …

Pfizer to submit evidence to NICE inquiry

February 16, 2007
Sales and Marketing

Pfizer has confirmed that it is to submit evidence to a forthcoming inquiry into the workings of NICE.The Commons Health …

Sanofi-Aventis growth stifled by Plavix and price cuts

February 15, 2007
Sales and Marketing

Figures show that Sanofi-Aventis continued to grow in 2006, despite its complaints about pressure in the US from generic manufacturers …

New HIV therapy to be fast-tracked

February 15, 2007
Research and Development

A new treatment for HIV is to be fast-tracked in Europe and the US.Pfizer's new compound maraviroc is to receive …

UK biotech consortium wins major grant for cutting-edge gene therapy

February 14, 2007
Research and Development

The EU has granted London-based Ark Therapeutics £1.65 million to fund research into using insect-derived viruses for producing genetic medicines.Ark …

UK pharma and government launch new collaboration

February 14, 2007
Research and Development

A collaboration between GlaxoSmithKline, Boehringer Ingelheim, Pfizer and East Lincolnshire PCT has been heralded as the future of healthcare in …

NICE set to appraise obesity treatment Accomplia

February 14, 2007
Sales and Marketing

Sanofi-Aventis' obesity treatment Acomplia (rimonabant) will be among the drugs appraised by NICE in its latest works programme. With an …

New anti-clotting antibody enters trials

February 12, 2007
Research and Development, Sales and Marketing

European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …

Flexing pharma’s competitive muscles

February 12, 2007
Sales and Marketing sales, strategy

It is universally acknowledged, almost to the point of cliche, that pharmaceutical companies operate in a highly competitive environment. Ensuring …

GlaxoSmithKline plans five launches for 2007

February 9, 2007
Sales and Marketing GSK

GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …

Cholesterol drugs boost Schering-Plough

February 9, 2007
Sales and Marketing Merck, Schering-Plough

A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …

The Gateway to Local Adoption Series

Latest content